Read on Twitter
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals
Papier (preprint) sur la vaccination en Israël et les variants. Apparition plus marquée d'infection postvac avec GB et SudAf que le WT. https://www.medrxiv.org/content/10.1101/2021.04.06.21254882v1
Papier (preprint) sur la vaccination en Israël et les variants. Apparition plus marquée d'infection postvac avec GB et SudAf que le WT. https://www.medrxiv.org/content/10.1101/2021.04.06.21254882v1
Rassurant néanmoins
"These results overall suggest that vaccine breakthrough infection is more frequent with both VOCs, yet a combination of mass-vaccination with two doses coupled with non-pharmaceutical interventions control and contain their spread."
"These results overall suggest that vaccine breakthrough infection is more frequent with both VOCs, yet a combination of mass-vaccination with two doses coupled with non-pharmaceutical interventions control and contain their spread."
@EricBillyFR @Le___Doc @FZores @CovaFlorian @mimiryudo @Scintigraphiste @DavidHajage @AnthonyGuihur @nathanpsmad @T_Fiolet @MS_Yahya_ @Nibor_Tolum
J'ajoute un passage intéressant:
"Vaccinees infected at least a week after the second dose were disproportionally infected with B.1.351 (odds ratio of 8:1). Those infected between two weeks after the first dose and one week after the second dose, were disproportionally
"Vaccinees infected at least a week after the second dose were disproportionally infected with B.1.351 (odds ratio of 8:1). Those infected between two weeks after the first dose and one week after the second dose, were disproportionally
infected by B.1.1.7 (odds ratio of 26:10), suggesting reduced vaccine effectiveness against both VOCs under different dosage/timing conditions."
